OTHER
Therapeutics
Review: lamotrigine may be an effective treatment for clozapine resistant schizophrenia
| The first 150 words of the full text of this article appear below. |
Is lamotrigine an effective and safe augmentation treatment in schizophrenic patients who are resistant to clozapine?
Total symptom score, positive and negative subscales of the Positive and Negative Syndrome Scale (PANSS) or the Brief Psychiatric Rating Scale (BPRS), and adverse events.
Systematic review with meta-analysis.
The Cochrane Schizophrenia Groups PsiTri database was searched without year or language limits. This database includes trials identified from regular searches of MEDLINE, EMBASE, CENTRAL, CINAHL, PsycINFO and BIOSIS Inside as well as conference proceedings and relevant journals. Clinical trials registers, relevant journals and reference lists of included studies were also searched and authors were contacted for further information.
Randomised controlled trials in people with schizophrenia receiving clozapine, which compared lamotrigine with placebo, were included. It was not reported how many reviewers selected the studies. Two reviewers independently extracted the data and assessed study quality based on the level of allocation concealment; studies at
Harvard Medical School, Boston, Massachusetts, USA
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
